M

Maccura Biotechnology Co Ltd
SZSE:300463

Watchlist Manager
Maccura Biotechnology Co Ltd
SZSE:300463
Watchlist
Price: 13.84 CNY -4.95% Market Closed
Market Cap: 8.5B CNY
Have any thoughts about
Maccura Biotechnology Co Ltd?
Write Note

Maccura Biotechnology Co Ltd
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Maccura Biotechnology Co Ltd
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
M
Maccura Biotechnology Co Ltd
SZSE:300463
Cash from Investing Activities
-ÂĄ739.6m
CAGR 3-Years
0%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Cash from Investing Activities
-ÂĄ8B
CAGR 3-Years
3%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Cash from Investing Activities
-ÂĄ1.4B
CAGR 3-Years
26%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Cash from Investing Activities
-ÂĄ2B
CAGR 3-Years
43%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Cash from Investing Activities
-ÂĄ5.7B
CAGR 3-Years
-16%
CAGR 5-Years
-77%
CAGR 10-Years
-28%
W
WuXi XDC Cayman Inc
HKEX:2268
Cash from Investing Activities
-ÂĄ91.2m
CAGR 3-Years
-20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Maccura Biotechnology Co Ltd
Glance View

Market Cap
8.5B CNY
Industry
Life Sciences Tools & Services

Maccura Biotechnology Co., Ltd. engages in the research, development, production, sale, and service of in vitro diagnostic products. The company is headquartered in Chengdu, Sichuan and currently employs 2,901 full-time employees. The company went IPO on 2015-05-28. The firm provides hundreds of products which cover clinical biochemistry, chemiluminescent immunoassay, rapid diagnosis, thrombosis, hemostasis, and molecular diagnosis.

Intrinsic Value
13.67 CNY
Overvaluation 1%
Intrinsic Value
Price
M

See Also

What is Maccura Biotechnology Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-739.6m CNY

Based on the financial report for Sep 30, 2024, Maccura Biotechnology Co Ltd's Cash from Investing Activities amounts to -739.6m CNY.

What is Maccura Biotechnology Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-10%

Over the last year, the Cash from Investing Activities growth was 4%.

Back to Top